AiXin Life International, Inc. engages in the sale of health supplement products. The firm through its subsidiary, AiXinZhonghong, markets and sells nutritional products directly to clients. The company was founded on December 30, 1987 and is headquartered in Chengdu, China.
Company profile
Ticker
AIXN
Exchange
CEO
Quan Zhong Lin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
MERCARI COMMUNICATIONS GROUP LTD
SEC CIK
Corporate docs
Subsidiaries
AiXin (BVI) International Group Co., Ltd • HK AiXin International Group Co., Limited • Chengdu AiXin Zhonghong Biological Technology Co., Ltd. • AiXin Life International Group, Inc. • Aixin Shangyan Hotel Management Co., Ltd. • Aixintang Pharmacy Co., Ltd. • Chengdu Aixintang Pharmacy Co., Ltd. • Chengdu Aixintang Liucheng Pharmacy Co., Ltd. • Chengdu Wenjiang Aixinhui Pharmacy Co., Ltd. • Chengdu Beibang Pharmacy Co., Ltd. ...
IRS number
841085935
AIXN stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
8 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
S-1/A
IPO registration (amended)
9 Feb 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
18 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
UPLOAD
Letter from SEC
27 Jul 23
S-1/A
IPO registration (amended)
25 Jul 23
CORRESP
Correspondence with SEC
20 Jul 23
UPLOAD
Letter from SEC
7 Jul 23
Latest ownership filings
SC 13D
Wang Yao-Te
13 Feb 23
SC 13D
Lin Quanzhong
13 Feb 23
3
Hsin-Liang Christopher Lee
24 Jan 23
3
Quanzhong Lin
12 Jul 18
3
Yao-Te Wang
12 Jul 18
3
Guolu Li
10 Jul 18
4
Maria I. Echevarria
23 Jan 17
4
Change in insider ownership
23 Jan 17
4
SCOTT L MATHIS
23 Jan 17
4
PETER J.L. LAWRENCE
23 Jan 17
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 498.34 k | 498.34 k | 498.34 k | 498.34 k | 498.34 k | 498.34 k |
Cash burn (monthly) | (no burn) | 406.71 k | 245.09 k | 159.68 k | (no burn) | 35.99 k |
Cash used (since last report) | n/a | 2.70 mm | 1.63 mm | 1.06 mm | n/a | 239.30 k |
Cash remaining | n/a | -2.21 mm | -1.13 mm | -563.37 k | n/a | 259.03 k |
Runway (months of cash) | n/a | -5.4 | -4.6 | -3.5 | n/a | 7.2 |